Found 17 matching trials
NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial PHASE2 This phase II trial tests how well liposomal irinotecan, oxaliplatin, 5-flu...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer PHASE2 This phase II trial tests whether pegylated SN-38 conjugate PLX038 (PLX038)...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations PHASE3 This phase III trial compares the effect of adding panitumumab to standard ...
Show More Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy PHASE2 This phase II trial compares the effect of sacituzumab govitecan and bevaci...
Show More Location
Multiple Locations
Learn More & Join Trial
S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer PHASE1 This partially randomized phase I/II trial studies the side effects and bes...
Show More Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer PHASE2 This phase II trial studies how well pegylated irinotecan NKTR 102 works in...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer PHASE2 To determine the safety and tolerability of adding durvalumab to mFOLFIRINO...
Show More Status
Active Not Recruiting
Location
GenesisCare North Shore
Learn More & Join Trial
Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer PHASE2 The primary objective of this study was to determine the progression free s...
Show More Location
Smilow Cancer Center
Learn More & Join Trial
Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer PHASE2 This phase 2 trial evaluates how well pegylated irinotecan (NKTR-102) works...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer PHASE3 This phase III trial compares the effect of dose-escalated radiation therap...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial